{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal stem Myocardial Infarction",
            "NStudiesAvail": 430108,
            "NStudiesFound": 46,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 46,
            "FieldList": [
                  "OutcomeClassDenomCountGroupId",
                  "OutcomeClassDenomCountValue",
                  "OutcomeClassDenomUnits",
                  "OutcomeClassTitle",
                  "OutcomeDenomCountGroupId",
                  "OutcomeDenomCountValue",
                  "OutcomeDenomUnits",
                  "OutcomeGroupDescription",
                  "OutcomeGroupId",
                  "OutcomeGroupTitle",
                  "OutcomeMeasureAnticipatedPostingDate",
                  "OutcomeMeasureCalculatePct",
                  "OutcomeMeasureDenomUnitsSelected",
                  "OutcomeMeasureDescription",
                  "OutcomeMeasureDispersionType",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT01392105"
                        ]
                  },
                  {
                        "Rank": 2,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT04421274"
                        ]
                  },
                  {
                        "Rank": 3,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT01291329"
                        ]
                  },
                  {
                        "Rank": 4,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT00114452"
                        ]
                  },
                  {
                        "Rank": 5,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT04056819"
                        ]
                  },
                  {
                        "Rank": 6,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT04340609"
                        ]
                  },
                  {
                        "Rank": 7,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT01394432"
                        ]
                  },
                  {
                        "Rank": 8,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT01652209"
                        ]
                  },
                  {
                        "Rank": 9,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT03798353"
                        ]
                  },
                  {
                        "Rank": 10,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT00883727"
                        ]
                  },
                  {
                        "Rank": 11,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT00877903"
                        ]
                  },
                  {
                        "Rank": 12,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT02672267"
                        ]
                  },
                  {
                        "Rank": 13,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT04551443"
                        ]
                  },
                  {
                        "Rank": 14,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT03047772"
                        ]
                  },
                  {
                        "Rank": 15,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT05043610"
                        ]
                  },
                  {
                        "Rank": 16,
                        "OutcomeClassDenomCountGroupId": [
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001"
                        ],
                        "OutcomeClassDenomCountValue": [
                              "15",
                              "15",
                              "12",
                              "13",
                              "15",
                              "15",
                              "12",
                              "13",
                              "15",
                              "15",
                              "14",
                              "12",
                              "13",
                              "14",
                              "15",
                              "15",
                              "14",
                              "15",
                              "14",
                              "14",
                              "14",
                              "14",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "14",
                              "14",
                              "14",
                              "14",
                              "14",
                              "14",
                              "14",
                              "14",
                              "14",
                              "14",
                              "14",
                              "14",
                              "15",
                              "15",
                              "15",
                              "15",
                              "14",
                              "14",
                              "15",
                              "15",
                              "14",
                              "14",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "14",
                              "14",
                              "14",
                              "15",
                              "14",
                              "14",
                              "13",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "12",
                              "14",
                              "12",
                              "14",
                              "12",
                              "14",
                              "14",
                              "13",
                              "15",
                              "15",
                              "14",
                              "14",
                              "15",
                              "15"
                        ],
                        "OutcomeClassDenomUnits": [
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants"
                        ],
                        "OutcomeClassTitle": [
                              "Baseline",
                              "12 Months",
                              "at 6 months",
                              "at 12 months",
                              "Baseline",
                              "6 months",
                              "12 months",
                              "Baseline",
                              "3 months",
                              "6 months",
                              "12 months",
                              "Baseline to 3 months, Improved",
                              "Baseline to 3 months, Unchanged",
                              "Baseline to 3 months, Worsened",
                              "Baseline to 6 months, Improved",
                              "Baseline to 6 months, Unchanged",
                              "Baseline to 6 months, Worsened",
                              "Baseline to 12 months, Improved",
                              "Baseline to 12 months, Unchanged",
                              "Baseline to 12 months, Worsened",
                              "1 month from injection",
                              "6 months from injection",
                              "12 months from injection",
                              "Treatment emergent AE (6 month)",
                              "Treatment emergent AE (12 months)",
                              "Baseline",
                              "3 months",
                              "6 months",
                              "12 months",
                              "Month 6",
                              "Month 12",
                              "baseline, normal",
                              "baseline, abnormal not clinically significant",
                              "baseline, abnormal, clinically significant",
                              "12 months, normal",
                              "12 months, abnormal not clinically significant",
                              "12 months, abnormal, clinically significant",
                              "12-hours post-catheterization",
                              "24-hours post-catheterization",
                              "Normal",
                              "Abnormal, Not Clinically Significant",
                              "Abnormal, Clinically Significant",
                              "12 hour post catheterization",
                              "24 hour post catheterization"
                        ],
                        "OutcomeDenomCountGroupId": [
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001"
                        ],
                        "OutcomeDenomCountValue": [
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "0",
                              "0",
                              "0",
                              "0",
                              "0",
                              "0",
                              "12",
                              "13",
                              "0",
                              "0",
                              "0",
                              "0",
                              "12",
                              "13",
                              "0",
                              "0",
                              "15",
                              "15",
                              "0",
                              "0",
                              "15",
                              "15",
                              "7",
                              "8",
                              "15",
                              "15"
                        ],
                        "OutcomeDenomUnits": [
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants"
                        ],
                        "OutcomeGroupDescription": [
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection"
                        ],
                        "OutcomeGroupId": [
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001"
                        ],
                        "OutcomeGroupTitle": [
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs"
                        ],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [
                              "Incidence (at one month post-catheterization) of any treatment-emergent serious adverse events, defined as the composite of: death, non-fatal MI, stroke, hospitalization for worsening heart failure, cardiac perforation, pericardial tamponade, sustained ventricular arrhythmias (characterized by ventricular arrhythmias lasting longer than 15 seconds or with hemodynamic compromise).",
                              "Determined by delayed contrast enhanced Computed Tomography (CT) Scan",
                              "Tissue perfusion measured by CT.",
                              "Peak VO2 assessed via treadmill determination.",
                              "A test that measures how far a patient can walk in 6 minutes.",
                              "Changed in NYHA Functional Classification will be evaluated. Worsened: Documented increase in limitation in physical activity. Improved: Documented decrease in limitation in physical activity. Unchanged: No documented change in limitation in physical activity.",
                              "Incidence of the Major Adverse Cardiac Events (MACE) endpoint, defined as the composite incidence of (1) death, (2) hospitalization for worsening heart failure, or (3) non-fatal recurrent MI.",
                              "Incidence of Treatment Emergent Adverse Event defined as any untoward medical occurrence in a patient or clinical investigation subject temporally associated with the use of the study product.",
                              "Minnesota Living with Heart Failure (MLHF) Questionnaire has a total score from 0 to 105. A higher score indicates that participant's heart failure is preventing them from living their life.",
                              "Left ventricular end diastolic wall thickness as determined by echocardiogram.",
                              "As determined by Computed Tomography Scan",
                              "As determined by Computed Tomography Scan",
                              "As determined by Computed Tomography Scan",
                              "Change in 1-year LVEF by CT as compared to baseline.",
                              "As assessed via ECHO",
                              "Difference in left ventricular end diastolic and end systolic volume will be assessed via ECHO",
                              "Difference in left ventricular end diastolic and end systolic volume will be assessed via CT",
                              "As measured via myocardial mass by CT",
                              "The number of participants with abnormal ECG readings via 24 hour ambulatory ECG recordings as assessed per treating physician discretion.",
                              "Clinical significance of abnormal lab values will be assessed by treating physician",
                              "Serial Troponin I values in ng/mL over time.",
                              "The number of participants with abnormal reading post-cardiac catheterization. As assessed per treating physician discretion.",
                              "CK-MB values in ng/mL over time."
                        ],
                        "OutcomeMeasureDispersionType": [
                              "Inter-Quartile Range",
                              "Standard Deviation",
                              "Standard Deviation",
                              "Inter-Quartile Range",
                              "Inter-Quartile Range",
                              "Full Range",
                              "Full Range",
                              "Full Range",
                              "Full Range"
                        ],
                        "NCTId": [
                              "NCT02013674"
                        ]
                  },
                  {
                        "Rank": 17,
                        "OutcomeClassDenomCountGroupId": [
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001"
                        ],
                        "OutcomeClassDenomCountValue": [
                              "6",
                              "2",
                              "5",
                              "2",
                              "6",
                              "2",
                              "6",
                              "2",
                              "6",
                              "2",
                              "5",
                              "2",
                              "5",
                              "2",
                              "5",
                              "2",
                              "6",
                              "2",
                              "3",
                              "2",
                              "5",
                              "2"
                        ],
                        "OutcomeClassDenomUnits": [
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants"
                        ],
                        "OutcomeClassTitle": [
                              "6 Months",
                              "18 Months",
                              "Baseline",
                              "18 Months",
                              "Baseline",
                              "18 Months",
                              "Baseline",
                              "18 Months",
                              "End Diastolic Volume from Baseline to 6 Months",
                              "End Diastolic from 6 Month to 18 Month",
                              "End Systolic Volume from Baseline to 6 Months",
                              "End Systolic from 6 Month to 18 Month",
                              "Baseline to 6 Months",
                              "Baseline to 18 Months",
                              "Baseline to 6 Months",
                              "Baseline to 18 Months",
                              "Baseline to 6 Months",
                              "Baseline to 18 Months",
                              "Baseline to 6 Months, Worsened",
                              "Baseline to 6 Months, Improved",
                              "Baseline to 6 Months, Unchanged",
                              "6 Months to 18 Months, Worsened",
                              "6 Months to 18 Months, Improved",
                              "6 Months to 18 Months, Unchanged",
                              "6 Month Visit",
                              "18 Month Visit",
                              "6 Month Visit",
                              "12 Month Visit",
                              "18 Month Visit",
                              "Baseline to 6 Months",
                              "Baseline to 12 Months",
                              "Baseline to 18 Months",
                              "Baseline",
                              "12H",
                              "24H",
                              "36H",
                              "48H",
                              "Baseline",
                              "12H",
                              "24H",
                              "36H",
                              "48H",
                              "Clinically Significant Hematology Values",
                              "Clinically Significant Clinical Chemistry Values",
                              "Clinically Significant Urinalysis Values",
                              "6 Months Post CABG",
                              "12 Months Post CABG",
                              "18 Months Post CABG"
                        ],
                        "OutcomeDenomCountGroupId": [
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001"
                        ],
                        "OutcomeDenomCountValue": [
                              "6",
                              "3",
                              "6",
                              "2",
                              "6",
                              "2",
                              "6",
                              "2",
                              "6",
                              "2",
                              "6",
                              "2",
                              "6",
                              "2",
                              "6",
                              "2",
                              "6",
                              "2",
                              "6",
                              "3",
                              "6",
                              "2",
                              "6",
                              "3",
                              "6",
                              "2",
                              "6",
                              "2",
                              "6",
                              "3",
                              "6",
                              "3",
                              "6",
                              "2",
                              "6",
                              "3",
                              "6",
                              "3"
                        ],
                        "OutcomeDenomUnits": [
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants"
                        ],
                        "OutcomeGroupDescription": [
                              "Participants who received mesenchymal stem cell injections.",
                              "Participants who received placebo injections.",
                              "Participants who received mesenchymal stem cell injections.",
                              "Participants who received placebo injections.",
                              "Participants who received mesenchymal stem cell injections.",
                              "Participants who received placebo injections.",
                              "Participants who received mesenchymal stem cell injections.",
                              "Participants who received placebo injections.",
                              "Participants who received mesenchymal stem cell injections.",
                              "Participants who received placebo injections.",
                              "Participants who received mesenchymal stem cell injections.",
                              "Participants who received placebo injections.",
                              "Participants who received mesenchymal stem cell injections.",
                              "Participants who received placebo injections.",
                              "Participants who received mesenchymal stem cell injections.",
                              "Participants who received placebo injections.",
                              "Participants who received mesenchymal stem cell injections.",
                              "Participants who received placebo injections.",
                              "Participants who received mesenchymal stem cell injections.",
                              "Participants who received placebo injections.",
                              "Participants who received mesenchymal stem cell injections.",
                              "Participants who received placebo injections.",
                              "Participants who received mesenchymal stem cell injections.",
                              "Participants who received placebo injections.",
                              "Participants who received mesenchymal stem cell injections",
                              "Participants who received placebo injections.",
                              "Participants who received mesenchymal stem cell injections.",
                              "Participants who received placebo injections.",
                              "Participants who received mesenchymal stem cell injections.",
                              "Participants who received placebo injections.",
                              "Participants who received mesenchymal stem cell injections.",
                              "Participants who received placebo injections.",
                              "Participants who received mesenchymal stem cell injections.",
                              "Participants who received placebo injections.",
                              "Participants who received mesenchymal stem cell injections.",
                              "Participants who received placebo injections.",
                              "Participants who received mesenchymal stem cell injections.",
                              "Participants who received placebo injections."
                        ],
                        "OutcomeGroupId": [
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001"
                        ],
                        "OutcomeGroupTitle": [
                              "Treated Group (Low/High Doses)",
                              "Placebo Group",
                              "Treated Group (Low/High Doses)",
                              "Placebo Group",
                              "Treated Group (Low/High Doses)",
                              "Placebo Group",
                              "Treated Group (Low/High Doses)",
                              "Placebo Group",
                              "Treated Group (Low/High Doses)",
                              "Placebo Group",
                              "Treated Group (Low/High Doses)",
                              "Placebo Group",
                              "Treated Group (Low/High Doses)",
                              "Placebo Group",
                              "Treated Group (Low/High Doses)",
                              "Placebo Group",
                              "Treated Group (Low/High Doses)",
                              "Placebo Group",
                              "Treated Group (Low/High Doses)",
                              "Placebo Group",
                              "Treated Group (Low/High Doses)",
                              "Placebo Group",
                              "Treated Group (Low/High Doses)",
                              "Placebo Group",
                              "Treated Group (Low/High Doses)",
                              "Placebo Group",
                              "Treated Group (Low/High Doses)",
                              "Placebo Group",
                              "Treated Group (Low/High Doses)",
                              "Placebo Group",
                              "Treated Group (Low/High Doses)",
                              "Placebo Group",
                              "Treated Group (Low/High Doses)",
                              "Placebo Group",
                              "Treated Group (Low/High Doses)",
                              "Placebo Group",
                              "Treated Group (Low/High Doses)",
                              "Placebo Group"
                        ],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [
                              "Six-month post-CABG surgery serious adverse event (SAE) proportion of patients experiencing a composite of sustained ventricular arrhythmias, (lasting longer than 15 seconds), with hemodynamic compromise, sudden unexpected death at six months, ectopic tissue formation at 12 months by chest/abdomen/pelvis CT exam.",
                              "Change in infarct scar size (ISS) between baseline and 6-month and 18 month visits as determined by delayed contrast-enhanced MRI.",
                              "The Left Ventricular Function differences in the region of MSC injection were evaluated. LVF is evaluated via ECHO as the percentage of ejected blood.",
                              "Difference between baseline and 18 month regional left ventricular wall thickening as determined by MRI.",
                              "Difference between the baseline and 18 month left ventricular end diastolic wall thickness as determined by MRI and echocardiogram.",
                              "Change in left ventricular end diastolic and systolic volume as determined by MRI and echocardiogram.",
                              "Change between baseline to 6-month and 18-month left ventricular ejection fraction (LVEF) as determined by MRI and echocardiogram.",
                              "Change in Peak VO2 as determined by treadmill test (mL/mg/min) from Baseline to 6 and from baseline to 18 months",
                              "Change in Six Minute Walk Test (in meters) from Baseline to 6 Months and Baseline to 18 Months",
                              "Change in New York Heart Association (NYHA) Functional Classification based on patient's self reported activity level.\n\nWorsened: documented increase in limitations of physical activity as self-described by subject Improved: documented decrease in limitations of physical activity as self-described by subject Unchanged: no documented change in limitations of physical activity as self-described by subject",
                              "Minnesota Living with Heart Failure (MLHF) questionnaire has a total score from 0 to 105. A higher score indicates that participants heart failure is preventing them from living their lives measured at two time points.",
                              "Incidence of Major Adverse Cardiac Events (MACE). A composite incidence of (1) death, (2) hospitalization for heart failure, or (3) non-fatal recurrent Ml.",
                              "Ambulatory ECG monitoring is the most widely employed technology for the evaluation of a patient with symptoms suggestive of cardiac arrhythmia or conduction abnormality.\n\nWhen the patient returns for follow up the 48- Hour Ambulatory monitor provides the data to the site staff to detect any abnormal recordings based upon standard ECG protocol.",
                              "Change in Pulmonary Function from Baseline to 6 month, Baseline to 12 month, and Baseline to 18 month visits as measured by forced expiratory volume in 1 second (FEV1)",
                              "Serial Troponin Values (ng/mL) Values from Baseline to 48 Hours Post CABG",
                              "Creatinine Kinase MB (ng/mL) Values every 12 hours from Baseline to 48 Hours Post CABG",
                              "Clinically significant laboratory values are first determined via standard laboratory normal values from a CAP and CLIA certified Laboratory and then assessed by investigator based on specific patient conditions and disease state.",
                              "Rate of Treatment Emergent Adverse Events Post Coronary Artery Bypass Graft (CABG) at 6 Months, 12 Months, and 18 Months",
                              "The number of abnormal Echocardiogram readings 2 Days Post CABG will be documented based on transthoracic Echocardiographic standards. However, although Echocardiograms 2 days post CABG operation may show abnormalities which is standard in this population, this testing is instrumental because it measures End- diastolic wall thickness and Left ventricular volumes at end-diastole and end-systole."
                        ],
                        "OutcomeMeasureDispersionType": [
                              "95% Confidence Interval",
                              "Standard Error",
                              "Standard Error",
                              "Standard Error",
                              "95% Confidence Interval",
                              "95% Confidence Interval",
                              "95% Confidence Interval",
                              "95% Confidence Interval",
                              "95% Confidence Interval",
                              "95% Confidence Interval",
                              "95% Confidence Interval",
                              "95% Confidence Interval",
                              "95% Confidence Interval"
                        ],
                        "NCTId": [
                              "NCT00587990"
                        ]
                  },
                  {
                        "Rank": 18,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT03902067"
                        ]
                  },
                  {
                        "Rank": 19,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT03404063"
                        ]
                  },
                  {
                        "Rank": 20,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT04939077"
                        ]
                  },
                  {
                        "Rank": 21,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [
                              "Baseline",
                              "13-Month",
                              "Baseline",
                              "13-Month",
                              "Baseline",
                              "13-Month",
                              "Baseline",
                              "Month 13",
                              "Improved NYHA Class",
                              "No change in NYHA Class",
                              "Worsened NYHA Class"
                        ],
                        "OutcomeDenomCountGroupId": [
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001"
                        ],
                        "OutcomeDenomCountValue": [
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "14",
                              "14"
                        ],
                        "OutcomeDenomUnits": [
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants"
                        ],
                        "OutcomeGroupDescription": [
                              "Participants will receive an injection of 20 million, 100 million or 200 million allogeneic human mesenchymal stem cells.\n\nAllo-hMSCs : Biological: Allogeneic human mesenchymal stem cells (Allo-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Allo-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Allo-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Allo-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million autologous human mesenchymal stem cells.\n\nAuto-hMSCs : Biological: Autologous human mesenchymal stem cells (Auto-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Auto-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Auto-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Auto-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million allogeneic human mesenchymal stem cells.\n\nAllo-hMSCs : Biological: Allogeneic human mesenchymal stem cells (Allo-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Allo-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Allo-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Allo-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million autologous human mesenchymal stem cells.\n\nAuto-hMSCs : Biological: Autologous human mesenchymal stem cells (Auto-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Auto-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Auto-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Auto-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million allogeneic human mesenchymal stem cells.\n\nAllo-hMSCs : Biological: Allogeneic human mesenchymal stem cells (Allo-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Allo-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Allo-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Allo-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million autologous human mesenchymal stem cells.\n\nAuto-hMSCs : Biological: Autologous human mesenchymal stem cells (Auto-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Auto-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Auto-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Auto-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million allogeneic human mesenchymal stem cells.\n\nAllo-hMSCs : Biological: Allogeneic human mesenchymal stem cells (Allo-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Allo-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Allo-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Allo-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million autologous human mesenchymal stem cells.\n\nAuto-hMSCs : Biological: Autologous human mesenchymal stem cells (Auto-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Auto-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Auto-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Auto-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million allogeneic human mesenchymal stem cells.\n\nAllo-hMSCs : Biological: Allogeneic human mesenchymal stem cells (Allo-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Allo-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Allo-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Allo-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million autologous human mesenchymal stem cells.\n\nAuto-hMSCs : Biological: Autologous human mesenchymal stem cells (Auto-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Auto-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Auto-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Auto-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million allogeneic human mesenchymal stem cells.\n\nAllo-hMSCs : Biological: Allogeneic human mesenchymal stem cells (Allo-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Allo-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Allo-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Allo-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million autologous human mesenchymal stem cells.\n\nAuto-hMSCs : Biological: Autologous human mesenchymal stem cells (Auto-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Auto-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Auto-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Auto-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million allogeneic human mesenchymal stem cells.\n\nAllo-hMSCs : Biological: Allogeneic human mesenchymal stem cells (Allo-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Allo-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Allo-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Allo-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million autologous human mesenchymal stem cells.\n\nAuto-hMSCs : Biological: Autologous human mesenchymal stem cells (Auto-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Auto-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Auto-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Auto-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million allogeneic human mesenchymal stem cells.\n\nAllo-hMSCs : Biological: Allogeneic human mesenchymal stem cells (Allo-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Allo-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Allo-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Allo-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million autologous human mesenchymal stem cells.\n\nAuto-hMSCs : Biological: Autologous human mesenchymal stem cells (Auto-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Auto-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Auto-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Auto-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million allogeneic human mesenchymal stem cells.\n\nAllo-hMSCs : Biological: Allogeneic human mesenchymal stem cells (Allo-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Allo-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Allo-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Allo-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million autologous human mesenchymal stem cells.\n\nAuto-hMSCs : Biological: Autologous human mesenchymal stem cells (Auto-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Auto-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Auto-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Auto-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter."
                        ],
                        "OutcomeGroupId": [
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001"
                        ],
                        "OutcomeGroupTitle": [
                              "Allo-hMSCs",
                              "Auto-hMSCs",
                              "Allo-hMSCs",
                              "Auto-hMSCs",
                              "Allo-hMSCs",
                              "Auto-hMSCs",
                              "Allo-hMSCs",
                              "Auto-hMSCs",
                              "Allo-hMSCs",
                              "Auto-hMSCs",
                              "Allo-hMSCs",
                              "Auto-hMSCs",
                              "Allo-hMSCs",
                              "Auto-hMSCs",
                              "Allo-hMSCs",
                              "Auto-hMSCs",
                              "Allo-hMSCs",
                              "Auto-hMSCs"
                        ],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [
                              "Percentage change from 13-months post-catheterization to baseline.",
                              "The Minnesota living with heart failure questionnaire uses a 6-point, zero to five, Likert scale. The total score is the sum of the 21 responses. The total score is considered the best measure of how heart failure and treatments impact a patients quality of life. The max score is 105, minimum score is 0. A lower score is considered a better quality of life."
                        ],
                        "OutcomeMeasureDispersionType": [
                              "95% Confidence Interval",
                              "95% Confidence Interval",
                              "95% Confidence Interval",
                              "95% Confidence Interval",
                              "95% Confidence Interval",
                              "95% Confidence Interval",
                              "95% Confidence Interval",
                              "95% Confidence Interval"
                        ],
                        "NCTId": [
                              "NCT01087996"
                        ]
                  },
                  {
                        "Rank": 22,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT01770613"
                        ]
                  },
                  {
                        "Rank": 23,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT02666391"
                        ]
                  },
                  {
                        "Rank": 24,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [
                              "Yes",
                              "No",
                              "Baseline",
                              "12-hours post-catheterization",
                              "24-hours post-catheterization",
                              "36-hours post-catheterization",
                              "48-hours post-catheterization",
                              "Baseline",
                              "12-hours post-catheterization",
                              "24-hours post-catheterization",
                              "36-hours post-catheterization",
                              "48-hours post-catheterization",
                              "Yes",
                              "No",
                              "Yes",
                              "No",
                              "Yes",
                              "No"
                        ],
                        "OutcomeDenomCountGroupId": [
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG000",
                              "OG001",
                              "OG002"
                        ],
                        "OutcomeDenomCountValue": [
                              "19",
                              "19",
                              "21",
                              "19",
                              "19",
                              "21",
                              "19",
                              "19",
                              "21",
                              "19",
                              "19",
                              "21",
                              "19",
                              "19",
                              "21",
                              "19",
                              "19",
                              "21",
                              "16",
                              "17",
                              "19",
                              "16",
                              "17",
                              "15",
                              "14",
                              "15",
                              "16"
                        ],
                        "OutcomeDenomUnits": [
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants"
                        ],
                        "OutcomeGroupDescription": [
                              "Autologous human mesenchymal cells (hMSCs): Participants will receive 40 million cells/mL delivered in a dose of 0.5 mL per injection for a total of 2 x 108 (200 million) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Autologous human bone marrow cells (hBMCs): Participants will receive 40 million cells/mL delivered in a dose of 0.5 mL per injection for a total of 2 x 108 (200 million) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Placebo: Participants will receive 0.5 mL injections of phosphate-buffered saline (PBS) and 1% human serum albumin (HAS) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Autologous human mesenchymal cells (hMSCs): Participants will receive 40 million cells/mL delivered in a dose of 0.5 mL per injection for a total of 2 x 108 (200 million) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Autologous human bone marrow cells (hBMCs): Participants will receive 40 million cells/mL delivered in a dose of 0.5 mL per injection for a total of 2 x 108 (200 million) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Placebo: Participants will receive 0.5 mL injections of phosphate-buffered saline (PBS) and 1% human serum albumin (HAS) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Autologous human mesenchymal cells (hMSCs): Participants will receive 40 million cells/mL delivered in a dose of 0.5 mL per injection for a total of 2 x 108 (200 million) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Autologous human bone marrow cells (hBMCs): Participants will receive 40 million cells/mL delivered in a dose of 0.5 mL per injection for a total of 2 x 108 (200 million) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Placebo: Participants will receive 0.5 mL injections of phosphate-buffered saline (PBS) and 1% human serum albumin (HAS) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Autologous human mesenchymal cells (hMSCs): Participants will receive 40 million cells/mL delivered in a dose of 0.5 mL per injection for a total of 2 x 108 (200 million) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Autologous human bone marrow cells (hBMCs): Participants will receive 40 million cells/mL delivered in a dose of 0.5 mL per injection for a total of 2 x 108 (200 million) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Placebo: Participants will receive 0.5 mL injections of phosphate-buffered saline (PBS) and 1% human serum albumin (HAS) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Autologous human mesenchymal cells (hMSCs): Participants will receive 40 million cells/mL delivered in a dose of 0.5 mL per injection for a total of 2 x 108 (200 million) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Autologous human bone marrow cells (hBMCs): Participants will receive 40 million cells/mL delivered in a dose of 0.5 mL per injection for a total of 2 x 108 (200 million) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Placebo: Participants will receive 0.5 mL injections of phosphate-buffered saline (PBS) and 1% human serum albumin (HAS) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Autologous human mesenchymal cells (hMSCs): Participants will receive 40 million cells/mL delivered in a dose of 0.5 mL per injection for a total of 2 x 108 (200 million) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Autologous human bone marrow cells (hBMCs): Participants will receive 40 million cells/mL delivered in a dose of 0.5 mL per injection for a total of 2 x 108 (200 million) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Placebo: Participants will receive 0.5 mL injections of phosphate-buffered saline (PBS) and 1% human serum albumin (HAS) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Autologous human mesenchymal cells (hMSCs): Participants will receive 40 million cells/mL delivered in a dose of 0.5 mL per injection for a total of 2 x 108 (200 million) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Autologous human bone marrow cells (hBMCs): Participants will receive 40 million cells/mL delivered in a dose of 0.5 mL per injection for a total of 2 x 108 (200 million) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Placebo: Participants will receive 0.5 mL injections of phosphate-buffered saline (PBS) and 1% human serum albumin (HAS) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Autologous human mesenchymal cells (hMSCs): Participants will receive 40 million cells/mL delivered in a dose of 0.5 mL per injection for a total of 2 x 108 (200 million) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Autologous human bone marrow cells (hBMCs): Participants will receive 40 million cells/mL delivered in a dose of 0.5 mL per injection for a total of 2 x 108 (200 million) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Placebo: Participants will receive 0.5 mL injections of phosphate-buffered saline (PBS) and 1% human serum albumin (HAS) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Autologous human mesenchymal cells (hMSCs): Participants will receive 40 million cells/mL delivered in a dose of 0.5 mL per injection for a total of 2 x 108 (200 million) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Autologous human bone marrow cells (hBMCs): Participants will receive 40 million cells/mL delivered in a dose of 0.5 mL per injection for a total of 2 x 108 (200 million) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Placebo: Participants will receive 0.5 mL injections of phosphate-buffered saline (PBS) and 1% human serum albumin (HAS) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter."
                        ],
                        "OutcomeGroupId": [
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG000",
                              "OG001",
                              "OG002"
                        ],
                        "OutcomeGroupTitle": [
                              "200 Million Autologous Human Mesenchymal Stem Cells (hMSCs)",
                              "200 Million Autologous Human Bone Marrow Cells (hBMCs)",
                              "Participants Will Receive a Placebo Injection of Phosphate-buf",
                              "200 Million Autologous Human Mesenchymal Stem Cells (hMSCs)",
                              "200 Million Autologous Human Bone Marrow Cells (hBMCs)",
                              "Participants Will Receive a Placebo Injection of Phosphate-buf",
                              "200 Million Autologous Human Mesenchymal Stem Cells (hMSCs)",
                              "200 Million Autologous Human Bone Marrow Cells (hBMCs)",
                              "Participants Will Receive a Placebo Injection of Phosphate-buf",
                              "200 Million Autologous Human Mesenchymal Stem Cells (hMSCs)",
                              "200 Million Autologous Human Bone Marrow Cells (hBMCs)",
                              "Participants Will Receive a Placebo Injection of Phosphate-buf",
                              "200 Million Autologous Human Mesenchymal Stem Cells (hMSCs)",
                              "200 Million Autologous Human Bone Marrow Cells (hBMCs)",
                              "Participants Will Receive a Placebo Injection of Phosphate-buf",
                              "200 Million Autologous Human Mesenchymal Stem Cells (hMSCs)",
                              "200 Million Autologous Human Bone Marrow Cells (hBMCs)",
                              "Participants Will Receive a Placebo Injection of Phosphate-buf",
                              "200 Million Autologous Human Mesenchymal Stem Cells (hMSCs)",
                              "200 Million Autologous Human Bone Marrow Cells (hBMCs)",
                              "Participants Will Receive a Placebo Injection of Phosphate-buf",
                              "200 Million Autologous Human Mesenchymal Stem Cells (hMSCs)",
                              "200 Million Autologous Human Bone Marrow Cells (hBMCs)",
                              "Participants Will Receive a Placebo Injection of Phosphate-buf",
                              "200 Million Autologous Human Mesenchymal Stem Cells (hMSCs)",
                              "200 Million Autologous Human Bone Marrow Cells (hBMCs)",
                              "Participants Will Receive a Placebo Injection of Phosphate-buf"
                        ],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [
                              "Data provided are with respect to the change from baseline at 12-months post-catheterization.",
                              "Data provided are with respect to the change from baseline at 12-months post-catheterization. The Minnesota living with heart failure questionnaire uses a 6-point, zero to five, Likert scale. The total score is the sum of the 21 responses. The total score is considered the best measure of how heart failure and treatments impact a patients quality of life. The max score is 105, minimum score is 0. A lower score is considered a better quality of life.",
                              "Data provided are with respect to the change from baseline at 12-months post-catheterization."
                        ],
                        "OutcomeMeasureDispersionType": [
                              "95% Confidence Interval",
                              "95% Confidence Interval",
                              "95% Confidence Interval",
                              "95% Confidence Interval",
                              "95% Confidence Interval"
                        ],
                        "NCTId": [
                              "NCT00768066"
                        ]
                  },
                  {
                        "Rank": 25,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT02368587"
                        ]
                  },
                  {
                        "Rank": 26,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT02503280"
                        ]
                  },
                  {
                        "Rank": 27,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT01076920"
                        ]
                  },
                  {
                        "Rank": 28,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT02504437"
                        ]
                  },
                  {
                        "Rank": 29,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT01753440"
                        ]
                  },
                  {
                        "Rank": 30,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT04388761"
                        ]
                  },
                  {
                        "Rank": 31,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT04551456"
                        ]
                  },
                  {
                        "Rank": 32,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT00515307"
                        ]
                  },
                  {
                        "Rank": 33,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT04850469"
                        ]
                  },
                  {
                        "Rank": 34,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT02398604"
                        ]
                  },
                  {
                        "Rank": 35,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT02439541"
                        ]
                  },
                  {
                        "Rank": 36,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT03525418"
                        ]
                  },
                  {
                        "Rank": 37,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [
                              "Upper respiratory tract infection",
                              "Ventricular tachycardia",
                              "Device Pacing issue",
                              "Peak VO2 (Baseline)",
                              "Peak VO2 (6 months)",
                              "Peak VO2 (1 year)",
                              "6 minute walk (Baseline)",
                              "6 minute walk (6 months)",
                              "6 minute walk (1 year)",
                              "Global ejection fraction (Baseline)",
                              "Global ejection fraction (1 year)",
                              "NYHA Class 1 (Baseline)",
                              "NYHA Class 2 (Baseline)",
                              "NYHA Class 3 (Baseline)",
                              "NYHA Class 1 (6 month)",
                              "NYHA Class 2 (6 month)",
                              "NYHA Class 3 (6 month)",
                              "NYHA Class 1 (12 month)",
                              "NYHA Class 2 (12 month)",
                              "NYHA Class 3 (12 month)",
                              "MLHF (Baseline)",
                              "MLHF (6 month)",
                              "MLHF (12 month)"
                        ],
                        "OutcomeDenomCountGroupId": [
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001"
                        ],
                        "OutcomeDenomCountValue": [
                              "16",
                              "18",
                              "16",
                              "18",
                              "16",
                              "18",
                              "16",
                              "18",
                              "18",
                              "19",
                              "16",
                              "18"
                        ],
                        "OutcomeDenomUnits": [
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants"
                        ],
                        "OutcomeGroupDescription": [
                              "Group 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAutologous hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.",
                              "Group 2 (18 patients) Eighteen (18) patients will be treated with allogeneic hMSCs (Allo-hMSCs): 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAllogeneic hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 2 (18 patients) Eighteen (18) patients will be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.",
                              "Group 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAutologous hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.",
                              "Group 2 (18 patients) Eighteen (18) patients will be treated with allogeneic hMSCs (Allo-hMSCs): 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAllogeneic hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 2 (18 patients) Eighteen (18) patients will be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.",
                              "Group 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAutologous hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.",
                              "Group 2 (18 patients) Eighteen (18) patients will be treated with allogeneic hMSCs (Allo-hMSCs): 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAllogeneic hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 2 (18 patients) Eighteen (18) patients will be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.",
                              "Group 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAutologous hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.",
                              "Group 2 (18 patients) Eighteen (18) patients will be treated with allogeneic hMSCs (Allo-hMSCs): 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAllogeneic hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 2 (18 patients) Eighteen (18) patients will be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.",
                              "Group 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAutologous hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.",
                              "Group 2 (18 patients) Eighteen (18) patients will be treated with allogeneic hMSCs (Allo-hMSCs): 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAllogeneic hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 2 (18 patients) Eighteen (18) patients will be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.",
                              "Group 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAutologous hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.",
                              "Group 2 (18 patients) Eighteen (18) patients will be treated with allogeneic hMSCs (Allo-hMSCs): 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAllogeneic hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 2 (18 patients) Eighteen (18) patients will be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs."
                        ],
                        "OutcomeGroupId": [
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001"
                        ],
                        "OutcomeGroupTitle": [
                              "Autologous hMSCs",
                              "Allogeneic hMSCs",
                              "Autologous hMSCs",
                              "Allogeneic hMSCs",
                              "Autologous hMSCs",
                              "Allogeneic hMSCs",
                              "Autologous hMSCs",
                              "Allogeneic hMSCs",
                              "Autologous hMSCs",
                              "Allogeneic hMSCs",
                              "Autologous hMSCs",
                              "Allogeneic hMSCs"
                        ],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [
                              "Incidence of TE-SAEs is defined as the composite of: death, non-fatal MI, stroke, hospitalization for worsening heart failure, cardiac perforation, pericardial tamponade, sustained ventricular arrhythmias (characterized by ventricular arrhythmias lasting longer than 15 seconds or with hemodynamic compromise), or any other potential late effects detected and corroborated by clinical presentation, laboratory investigations, image analysis and when necessary with biopsy from suspected target sites in the body.",
                              "Measurement of Peak oxygen consumption (Peak VO2) by treadmill determination during the 12 month follow-up period.",
                              "Measurement of Six-minute walk test during the 12 month follow-up period",
                              "Measurement of regional left ventricular function, end diastolic and end systolic volume, measured by MRI, and or CT, and echocardiogram.",
                              "Measurement of New York Heart Association (NYHA) functional class during the 12 month follow-up period.",
                              "Measurement of Minnesota Living with Heart Failure (MLHF) Questionnaire during the 12 month follow-up period. It measures the effects of symptoms, functional limitations, and psychological distress on an individual's quality of life. The response scale for all 21 items on the MLHF is based on a 6-point. The Maximum possible scores being 126 and the minimum 0. Higher scores indicate a worse or worsening quality of life, while lower scores or decreasing scores indicate a better quality of life."
                        ],
                        "OutcomeMeasureDispersionType": [
                              "Standard Deviation",
                              "Standard Deviation",
                              "Standard Deviation",
                              "Full Range"
                        ],
                        "NCTId": [
                              "NCT01392625"
                        ]
                  },
                  {
                        "Rank": 38,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT03478215"
                        ]
                  },
                  {
                        "Rank": 39,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT04011059"
                        ]
                  },
                  {
                        "Rank": 40,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT01720888"
                        ]
                  },
                  {
                        "Rank": 41,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT00418418"
                        ]
                  },
                  {
                        "Rank": 42,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [
                              "Baseline",
                              "5 years"
                        ],
                        "OutcomeDenomCountGroupId": [
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001"
                        ],
                        "OutcomeDenomCountValue": [
                              "55",
                              "55",
                              "55",
                              "55"
                        ],
                        "OutcomeDenomUnits": [
                              "Participants",
                              "Participants"
                        ],
                        "OutcomeGroupDescription": [
                              "55 patients were randomized to CD34+ cell transplantation (SC group). In the SC group, peripheral CD34+cells were mobilized by G-CSF and collected via apheresis. Patients underwent myocardial scintigraphy and CD34+ cells were injected in the artery supplying the segments with reduced viability",
                              "55 patients were randomized to standard medical therapy, without stem cell injection.",
                              "55 patients were randomized to CD34+ cell transplantation (SC group). In the SC group, peripheral CD34+cells were mobilized by G-CSF and collected via apheresis. Patients underwent myocardial scintigraphy and CD34+ cells were injected in the artery supplying the segments with reduced viability",
                              "55 patients were randomized to standard medical therapy, without stem cell injection."
                        ],
                        "OutcomeGroupId": [
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001"
                        ],
                        "OutcomeGroupTitle": [
                              "SC Group",
                              "Control Group",
                              "SC Group",
                              "Control Group"
                        ],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [
                              "Left ventricular ejection fraction measured by echocardiography"
                        ],
                        "OutcomeMeasureDispersionType": [
                              "Standard Deviation"
                        ],
                        "NCTId": [
                              "NCT00629018"
                        ]
                  },
                  {
                        "Rank": 43,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT02323477"
                        ]
                  },
                  {
                        "Rank": 44,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT01649752"
                        ]
                  },
                  {
                        "Rank": 45,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT02962661"
                        ]
                  },
                  {
                        "Rank": 46,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT03397095"
                        ]
                  }
            ]
      }
}